Skip to content

Sharp Dissection Versus Monopolar Electrocautery in Primary Total Knee Arthroplasty Performed Under Tourniquet

Sharp Dissection Versus Monopolar Electrocautery in Primary Total Knee Arthroplasty Performed Under Tourniquet: a Randomized Double Blind Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03559478
Enrollment
70
Registered
2018-06-18
Start date
2018-11-30
Completion date
2021-04-30
Last updated
2018-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Knee, Osteo Arthritis Knee

Brief summary

This study compares the use of sharp dissection with diathermy for the approach to a total knee replacement. Half of the patients will be randomly assigned each intervention.

Detailed description

The approach to the knee to carry out a total knee replacement (TKR) can either be carried out using a scalpel, sharp dissection, or using an electric current to divide tissue, monopoly electrocautery. Reducing blood loss is important. Blood loss can result in anaemia, which has a number of effects including shortness of breath, chest pain and lethargy. Blood loss into a newly replaced knee can also result in pain and stiffness in the joint. Total knee replacements are routinely carried out with a tourniquet inflated, which reduces the blood flow into to leg during the operation. Diathermy is applied to areas of bleeding to stop them from doing so during operations. With the tourniquet inflated, some areas that would bleed when this was deflated may not be noticed and continue to bleed. Using diathermy for the approach would be expected to reduce this bleeding compared to using a scalpel.

Interventions

PROCEDURESharp dissection with scalpel plus electrocautery to vessels

A scalpel will be used for dissection for TKA implantation. Bleeding vessels will be managed as encountered with electrocautery. Electrocautery will not be used for dissection.

PROCEDUREElectrocautery for all dissection

Skin incision will be made with a scalpel, but all other dissection will be performed with electrocautery.

Sponsors

Royal Infirmary of Edinburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Patients will be blinded to the intervention as they will be under anaesthetic whilst the procedure is being carried out.

Intervention model description

A total of 70 participants will be randomized in a 1:1 ratio to either Treatment Group 1 (sharp dissection with scalpel plus electrocautery to obvious vessels) or Treatment Group 2 (electrocautery for all dissection) using the sealed opaque envelope randomization technique.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Primary knee osteoarthritis requiring TKA (total knee arthroplasty) * Planned for cruciate retaining prosthesis without patella resurfacing * Patient is able to give informed consent * Patient resides locally and will be available for follow up

Exclusion criteria

* Cardiac pacemaker * Inflammatory arthropathy * Tourniquet contraindicated * Thrombophilia/haemoglobinopathy * Spinal anaesthetic not possible

Design outcomes

Primary

MeasureTime frameDescription
24hr Calculated blood loss1 dayWill be done using the Nadler and Gross formulae

Secondary

MeasureTime frameDescription
Transfusion requirement2 daysIf the patient requires blood transfusion or not
VAS (Visual Analogue Scale) pain score 24 and 48 hrs2 daysPatient's pain score at 24 and 48 hours post-operatively
Range of motion 48hrs and 6 weeks6 weeksKnee range of motion in degrees at 48 hours and 6 weeks post-operatively
Haemoglobin drop1 dayHaemoglobin drop from day 1 full blood count test
Improvement in Oxford knee score at 12 months12 monthsOxford Knee Score, designed to assess function and pain after total knee replacement. Scored from 0 (severe knee symptoms with functional limitation) to 60 (absence of pain and limitations)
Adverse events12 monthsAny complications encountered
Length of hospital stay2 weeksLength of inpatient stay in hospital

Countries

United Kingdom

Contacts

Primary ContactChloe EH Scott, MD MSc
chloe.scott@nhslothian.scot.nhs.uk01312423484
Backup ContactKatrina R Bell, MBChB
katrinabell@doctors.org.uk01312423480

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026